Education
About Us
Working with TipRanks
Follow Us
Amgen (HK:4332)
:4332
Total Valuation
Amgen has a market cap or net worth of $1.61T. The enterprise value is HK$251.87B.
Market Cap$1.61T
Enterprise ValueHK$251.87B
Share Statistics
Amgen has 539,067,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding539,067,700
Owned by Insiders0.19%
Owned by Institutions20.64%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 13.16%.
Return on Equity (ROE)0.89
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)13.16%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee1.31M
Profits Per Employee275.39K
Employee Count28,000
Asset Turnover0.41
Inventory Turnover1.72
Valuation Ratios
The current PE Ratio of Amgen is <0.1. Amgen’s PEG ratio is 0.26.
PE Ratio<0.1
PS Ratio4.79
PB Ratio20.34
Price to Fair Value20.34
Price to FCF21.74
Price to Operating Cash Flow20.72
PEG Ratio0.26
Income Statement
In the last 12 months, Amgen had revenue of 36.74B and earned 7.71B in profits. Earnings per share was 14.33.
Revenue36.74B
Gross Profit26.01B
Operating Income10.68B
Pretax Income8.98B
Net Income7.71B
EBITDA15.84B
Earnings Per Share (EPS)14.33
Cash Flow
In the last 12 months, operating cash flow was 9.96B and capital expenditures -1.86B, giving a free cash flow of 8.10B billion.
Operating Cash Flow9.96B
Free Cash Flow8.10B
Free Cash Flow per Share15.03
Dividends & Yields
Amgen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change-99.99%
50-Day Moving Average1.71K
200-Day Moving Average1.71K
Relative Strength Index (RSI)0.90
Average Volume (3m)0.00
Important Dates
Amgen upcoming earnings date is Apr 29, 2026, After Close (Confirmed).
Last Earnings DateFeb 3, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
Amgen as a current ratio of 1.14, with Debt / Equity ratio of 630.68%
Current Ratio1.14
Quick Ratio0.90
Debt to Market Cap0.31
Net Debt to EBITDA2.87
Interest Coverage Ratio3.88
Taxes
In the past 12 months, Amgen has paid 1.26B in taxes.
Income Tax1.26B
Effective Tax Rate0.14
Enterprise Valuation
Amgen EV to EBITDA ratio is 13.99, with an EV/FCF ratio of 27.35.
EV to Sales6.03
EV to EBITDA13.99
EV to Free Cash Flow27.35
EV to Operating Cash Flow22.25
Balance Sheet
Amgen has $9.13B in cash and marketable securities with $54.60B in debt, giving a net cash position of -$45.48B billion.
Cash & Marketable Securities$9.13B
Total Debt$54.60B
Net Cash-$45.48B
Net Cash Per Share-$84.36
Tangible Book Value Per Share-$60.03
Margins
Gross margin is 70.49%, with operating margin of 29.06%, and net profit margin of 20.99%.
Gross Margin70.49%
Operating Margin29.06%
Pretax Margin24.43%
Net Profit Margin20.99%
EBITDA Margin43.12%
EBIT Margin29.06%
Analyst Forecast
The average price target for Amgen is $2,815.82, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2,815.82
Price Target Upside1564242.00% Upside
Analyst ConsensusModerate Buy
Analyst Count25
Revenue Growth Forecast―
EPS Growth Forecast―